CDKN2A and colorectal cancer: The results showed that, compared with normal tissues, the expression of ADRA1B, CDKN2A, FCER2, and IL13 was significantly upregulated in colorectal cancer tissues, while CALM1, CTNNA1, GSR, INSR, and MAPK9 were significantly downregulated.